An International Publisher for Academic and Scientific Journals
Author Login
Scholars Journal of Medical Case Reports | Volume-14 | Issue-11
Primary Pulmonary Adenoid Cystic Carcinoma: A Case Report and Review of the Literature
S. Alkama*, K. El Fehmi, M. Darfaoui, R. Ousalm, T. Igarramen, S. Latitioui, M. Saadoune, N. Oumghar, S. Barkiche, A. Elomrani, M. Khouchani
Published: Nov. 21, 2026 |
5
3
Pages: 2813-2818
Downloads
Abstract
Primary pulmonary adenoid cystic carcinoma (PACC) is a rare salivary gland-type malignancy arising from the submucosal glands of the tracheobronchial tree. It is generally characterized by slow growth and an indolent clinical course. Complete surgical resection with negative margins remains the preferred treatment for localized disease. However, management of locally advanced unresectable tumors remains challenging, and evidence regarding definitive chemoradiotherapy is limited. A 47-year-old man, with a 24-year history of snuff tobacco use, presented with a 6-month history of hemoptysis, dry cough, dyspnea. Chest CT revealed a 60 mm locally infiltrative left mediastino-hilar endobronchial mass causing ipsilateral pulmonary collapse, initially staged as cT3 N2b M0. Bronchoscopy showed a highly vascularized, completely obstructive tumor of the left main bronchus. Initial histological examination suggested a poorly differentiated non-small cell carcinoma. Immunohistochemistry demonstrated strong expression of CD117 and p63, with negativity for TTF-1, synaptophysin, and chromogranin A, supporting the diagnosis of adenoid cystic carcinoma. PET-CT confirmed locally advanced disease with bilateral mediastinal lymph node involvement and suspected carcinomatous lymphangitis. An otorhinolaryngological evaluation, including bilateral tonsillectomy, excluded a head and neck primary tumor. Surgical resection was considered unfeasible because of extensive local invasion with tumor encasement of more than 180° of the aortic arch. The patient therefore received four cycles of induction cisplatin and vinorelbine, resulting in significant tumor regression, with improvement of pulmonary atelectasis and mediastinal lymphadenopathy. He subsequently underwent definitive concurrent chemoradiotherapy, consisting of intensity-modulated radiotherapy to 60 Gy in 30 fractions with concurrent cisplatin and vinorelbine. This case highlights the diagnostic and therapeutic challenges of locally a


